No Detail Found!

Assessment of Osteoporosis with Aspartate Aminotransferase to Platelet Ratio Index Score in Patients of Chronic Liver Disease

Author(s)
Farrukh Sher Department of Medicine, Pak Emirate Military Hospital/National University of Medical Sciences (NUMS) Rawalpindi,,Pakistan
Rao Saad Ali Khan Department of Gastroenterology,Combined Military Hospital, Malir/National University of Medical Sciences (NUMS) Pakistan
Sumeera Akram Department of Paeds, DHQ Hospital Zhob, Pakistan
Muhammad Ahmed Khan Department of ENT, Pak Emirate Military Hospital/National University of Medical Sciences (NUMS) Rawalpindi Pakistan
Qaiser Iqbal Department of Medicine, Pak Emirate Military Hospital/National University of Medical Sciences (NUMS) Rawalpindi,,Pakistan
Fahd Bin Haider Department of Medicine, Pak Emirate Military Hospital/National University of Medical Sciences (NUMS) Rawalpindi,,Pakistan
Khurram Hayat Healthcare Administrator, Pak Emirate Military Zhob/National University of Medical Sciences (NUMS) Rawalpindi Pakistan,
Abstract
Objective: to assess Osteoporosis with APRI score (aspartate aminotransferase to platelet ratio index) in patients with chronic liver disease. Study Design: Cross-sectional study. Study Setting and Duration: Pak Emirates Military Hospital Rawalpindi, Pakistan from Jan to Dec 2021. Methodology: All Adult patients aged 18 years and above with clinical and imaging features suggestive of chronic liver disease were included in the study. APRI score calculated as the ratio of aspartate aminotransferase to platelet based on the laboratory analysis of Aspartate aminotransferase (AST) and platelet levels was done. Furthermore, a bone density scan (DEXA scan) was also carried out for all the study participants. Results: One hundred and sixty patients fulfilling the inclusion criteria were included. Of the total 160 cases, 53(33.1%) had normal bone density on DEXA scans, 43(26.9%) had Osteopenia and 64(40%) had Osteoporosis. Twenty-nine cases of chronic liver disease cases (25%) had APRI scores 0.3 and0.5 and 1.5 and 2. The significant (p<0.001) association was observed between APRI score and bone density, showing bone density decreased with the progression of the disease. Conclusion: Patients with chronic liver disease almost invariably develop Osteoporosis with the progression of the disease. Early recognition and treatment are pivotal to lessen morbidity and mortality associated with Osteoporosis.
Publication Details
Page(s) 731-734
Published Journal: Pakistan Armed Forces Medical Journal, Volume: 73, Issue: 3, Year: 2023

Request the full text from PASTIC

Keywords
Osteopenia, Osteoporosis, Hepatitis C, Chronic Liver Disease, Aspartate Aminotransferase, Platelet.
0

Citations

0

Downloads

97

Views